Publications by authors named "Jelili Olaide Mustapha"

5 Publications

  • Page 1 of 1

Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19.

Heliyon 2021 Jan 9;7(1):e05951. Epub 2021 Jan 9.

Department of Nursing Sciences, Maryam Abacha American University of Niger, Maradi, Nigeria.

Several months after the emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), cases of re-infection after recovery were reported. The extent and duration of protective immunity after SARS-CoV-2 infection is not fully understood. As such, the possibility of re-infection with SARS-CoV-2. Furthermore, cases of re-infection were mainly due to different variants or mutant SARS-CoV-2. Following the fast and pandemic-scale spread of COVID-19, mutations in SARS-CoV-2 have raised new diagnostic challenges which include the redesign of the oligonucleotide sequences used in RT-PCR assays to avoid potential primer-sample mismatches, and decrease sensitivities. Since the initial wave of the pandemic, some regions had experienced fresh outbreaks, predisposing people to be susceptible to SARS-CoV-2 re-infection. Hence, this article sought to offer detailed biology of SARS-CoV-2 re-infections and their implications on immune response milieu, diagnostic laboratory tests and control measures against COVID-19.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.heliyon.2021.e05951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810769PMC
January 2021

Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.

Hum Vaccin Immunother 2021 03 16;17(3):620-637. Epub 2020 Sep 16.

Department of Medical Laboratory Science, Faculty of Allied Health Sciences, College of Medical Sciences, Ahmadu Bello University, Zaria, Nigeria.

The incidence and case-fatality rates (CFRs) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the etiological agent for Coronavirus Disease 2019 (COVID-19), have been rising unabated. Even though the entire world has been implementing infection prevention and control measures, the pandemic continues to spread. It has been widely accepted that preventive vaccination strategies are the public health measures for countering this pandemic. This study critically reviews the latest scientific advancement in genomics, replication pattern, pathogenesis, and immunopathology of SARS-CoV-2 infection and how these concepts could be used in the development of vaccines. We also offer a detailed discussion on the anticipated potency, efficacy, safety, and pharmaco-economic issues that are and will be associated with candidate COVID-19 vaccines.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1080/21645515.2020.1812313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993231PMC
March 2021

Exploring the genetics, ecology of SARS-COV-2 and climatic factors as possible control strategies against COVID-19

Infez Med 2020 Ahead Of Print Jun 1;28(2):166-173

Department of Public Health, University of South Wale, UK.

The world has been thrown into pandemonium due to the recent Coronavirus Disease-19 (COVID-19) pandemic. Early available clinical data have indicated that geriatric persons cum those with comorbidity such as cardiovascular, metabolic and immunological disorders suffered severe form of COVID-19. All countries and territories of the world are currently exploring available strategies to control the pandemic with the hope to significantly minimize its morbidity and mortality rate. This present study critically reviewed available and latest research progress on the genetics and ecology of SARS-CoV-2, as well as the influence of climatic factors on the spread of COVID-19, and thus, discussed how these concepts could be harnessed for COVID-19 control and further scientific advancements in resolving the pandemic.
View Article and Find Full Text PDF

Download full-text PDF

Source
April 2020

Epidemiology and Synergistic Hepatopathology of Malaria and Hepatitis C Virus Coinfection.

Virology (Auckl) 2017 4;8:1178122X17724411. Epub 2017 Aug 4.

Department of Medical Microbiology and Parasitology, Lagos State University Teaching Hospital, Lagos, Nigeria.

Malaria and hepatitis C virus (HCV) infections are very common causes of human suffering with overlapping global geographic distributions. With the growing incidence of HCV infections in malaria-endemic zones and malaria in areas with exceptionally high HCV prevalence, coinfections and syndemism of both pathogens are likely to occur. However, studies of malaria and HCV coinfections are very rare despite the fact that liver-stage plasmodiasis and hepatitis C develop in hepatocytes which may synergistically interact. The fact that both pathogens share similar entry molecules or receptors in early invasive steps of hepatocytes further makes hepatopathologic investigations of coinfected hosts greatly important. This review sought to emphasize the public health significance of malaria/HCV coinfections and elucidate the mechanisms of pathogens' entrance and invasion of susceptible host to improve on existing or develop antiplasmodial drugs and hepatitis C therapeutics that can intervene at appropriate stages of pathogens' life cycles.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1177/1178122X17724411DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546637PMC
August 2017

Survey of malaria and anti-dengue virus IgG among febrile HIV-infected patients attending a tertiary hospital in Abuja, Nigeria.

HIV AIDS (Auckl) 2017 30;9:145-151. Epub 2017 Jun 30.

Department of Medical Laboratory Services, University of Abuja Teaching Hospital, FCT Abuja, Nigeria.

Background: Dengue and malaria are infections, of great public health concern, especially in sub-Saharan Africa where the burden of HIV infection is high. This study was conducted to determine the seroprevalence of dengue virus IgG antibodies and dengue/malaria coinfection among febrile HIV-infected patients attending the University of Abuja Teaching Hospital, Gwagwalada, Abuja.

Methods: In this cross-sectional study, blood samples from 178 consenting HIV-infected patients receiving antiretroviral therapy were collected and tested for plasmodiasis and anti-Dengue virus IgG using malaria microscopy and ELISA, respectively. Interviewer-based questionnaires were used to assess subjects' sociodemographic variables and dengue risk factors.

Results: Of the 178 screened participants, 44.4% were seropositive for dengue virus IgG antibody, whereas 29.2% were positive for About 44.2% were positive for both dengue virus and . There was a statistical association between anti-dengue IgG and occupation (=0.03) but not with age, residential area, educational level and patients' gender (>0.05). Seroprevalence of anti-dengue specific IgG was relatively higher in participants who adopted protective measures. There was a statistical association between seroprevalence of anti-dengue IgG and adoption of preventive measures (<0.05).

Conclusion: The high prevalence of malaria and dengue virus IgG indicates the need to strengthen vector control and dengue surveillance programs.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.2147/HIV.S134023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501627PMC
June 2017
-->